| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Lars Muller CEO | XFRA Exchange | DE000A3E5A59 ISIN |
| Germany Country | 104 Employees | - Last Dividend | - Last Split | - IPO Date |
SynBiotic SE is a company dedicated to advancing the field of cannabinoid and terpene-based therapeutics, focusing on providing solutions for pain, sleep deprivation, and anxiety. Originating as Ledgertech SE, the company underwent a transformation to better align with its focus on cannabinoid solutions, adopting the name SynBiotic SE. Since its inception in 2015, SynBiotic SE has maintained its headquarters in Munich, Germany, positioning itself as a leader in both the research and development, as well as the production and marketing of its specialized products.
SynBiotic SE offers a diverse range of products under several brands, catering to both medical and recreational cannabis markets. Each product line is designed with specific needs in mind, from dietary supplements to medical cannabis products.